ADXN
Addex Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.51 / 10
Netural
ADXN's fundamentals score poorly (3.5/10). Key concerns include a 61% year-over-year revenue decline and a positive PB-ROE spread, outweighing moderate interest coverage. This combination suggests operational inefficiencies and limited value, leading to a 'selective' stance.
Analysis Checks(9/10)
Revenue-MV
Value-3.95
Score3/3
Weight22.92%
1M Return11.03%
Value-3.95
Score3/3
Weight22.92%
1M Return11.03%
Inventory turnover ratio
Value47.88
Score2/3
Weight-1.91%
1M Return-1.23%
Value47.88
Score2/3
Weight-1.91%
1M Return-1.23%
PB-ROE
Value0.33
Score1/3
Weight18.60%
1M Return8.79%
Value0.33
Score1/3
Weight18.60%
1M Return8.79%
Operating revenue (YoY growth rate %)
Value-61.46
Score2/3
Weight0.17%
1M Return0.10%
Value-61.46
Score2/3
Weight0.17%
1M Return0.10%
Net profit / Total profit (%)
Value97.65
Score2/3
Weight-1.57%
1M Return-0.98%
Value97.65
Score2/3
Weight-1.57%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value-61.56
Score3/3
Weight1.48%
1M Return0.88%
Value-61.56
Score3/3
Weight1.48%
1M Return0.88%
Profit-MV
Value0.47
Score2/3
Weight18.40%
1M Return8.99%
Value0.47
Score2/3
Weight18.40%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.99%
1M Return-1.25%
Value15.51
Score2/3
Weight-1.99%
1M Return-1.25%
Asset-MV
Value-0.51
Score2/3
Weight26.23%
1M Return12.15%
Value-0.51
Score2/3
Weight26.23%
1M Return12.15%
Cash-MV
Value-0.07
Score2/3
Weight17.66%
1M Return8.80%
Value-0.07
Score2/3
Weight17.66%
1M Return8.80%
Revenue-MV
Value-3.95
Score3/3
Weight22.92%
1M Return11.03%
Value-3.95
Score3/3
Weight22.92%
1M Return11.03%
Total operating revenue (YoY growth rate %)
Value-61.56
Score3/3
Weight1.48%
1M Return0.88%
Value-61.56
Score3/3
Weight1.48%
1M Return0.88%
Inventory turnover ratio
Value47.88
Score2/3
Weight-1.91%
1M Return-1.23%
Value47.88
Score2/3
Weight-1.91%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight18.40%
1M Return8.99%
Value0.47
Score2/3
Weight18.40%
1M Return8.99%
PB-ROE
Value0.33
Score1/3
Weight18.60%
1M Return8.79%
Value0.33
Score1/3
Weight18.60%
1M Return8.79%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-1.99%
1M Return-1.25%
Value15.51
Score2/3
Weight-1.99%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value-61.46
Score2/3
Weight0.17%
1M Return0.10%
Value-61.46
Score2/3
Weight0.17%
1M Return0.10%
Asset-MV
Value-0.51
Score2/3
Weight26.23%
1M Return12.15%
Value-0.51
Score2/3
Weight26.23%
1M Return12.15%
Net profit / Total profit (%)
Value97.65
Score2/3
Weight-1.57%
1M Return-0.98%
Value97.65
Score2/3
Weight-1.57%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight17.66%
1M Return8.80%
Value-0.07
Score2/3
Weight17.66%
1M Return8.80%
Is ADXN fundamentally strong?
- ADXN scores 3.51/10 on fundamentals and holds a Fair valuation at present. Backed by its -62.56% ROE, -5123.22% net margin, -1.20 P/E ratio, 1.30 P/B ratio, and -265.56% earnings growth, these metrics solidify its Netural investment rating.
